Thomas E. Carey

71.0k total citations · 3 hit papers
328 papers, 14.1k citations indexed

About

Thomas E. Carey is a scholar working on Molecular Biology, Oncology and Otorhinolaryngology. According to data from OpenAlex, Thomas E. Carey has authored 328 papers receiving a total of 14.1k indexed citations (citations by other indexed papers that have themselves been cited), including 142 papers in Molecular Biology, 125 papers in Oncology and 99 papers in Otorhinolaryngology. Recurrent topics in Thomas E. Carey's work include Head and Neck Cancer Studies (92 papers), Cancer-related Molecular Pathways (33 papers) and Head and Neck Surgical Oncology (33 papers). Thomas E. Carey is often cited by papers focused on Head and Neck Cancer Studies (92 papers), Cancer-related Molecular Pathways (33 papers) and Head and Neck Surgical Oncology (33 papers). Thomas E. Carey collaborates with scholars based in United States, Japan and Finland. Thomas E. Carey's co-authors include Carol R. Bradford, Gregory T. Wolf, Mark E. Prince, Douglas B. Chepeha, Jonathan B. McHugh, Avraham Eisbruch, Francis P. Worden, Kenneth D. McClatchey, Nisha J. D’Silva and Bhavna Kumar and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Thomas E. Carey

325 papers receiving 13.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeted Gold Nanoparticles Enable Molecular CT Imaging of Cancer

2008 608 citations Thomas E. Carey et al. profile →
EGFR, p16, HPV Titer, Bcl-xL and p53, Sex, and Smoking As Indicators of Response to Therapy and Survival in Oropharyngeal Cancer

2008 493 citations Francis P. Worden, Mark E. Prince et al. Journal of Clinical Oncology profile →
Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells.

1976 376 citations Thomas E. Carey et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Thomas E. Carey	6.2k	5.0k	3.6k	2.6k	2.5k	328	14.1k
Jeffrey N. Myers	6.5k 1.1×	6.5k 1.3×	3.6k 1.0×	2.9k 1.1×	2.7k 1.1×	359	15.7k
Reidar Grénman	5.4k 0.9×	5.0k 1.0×	2.5k 0.7×	2.8k 1.1×	3.4k 1.4×	356	13.7k
Ruud H. Brakenhoff	6.2k 1.0×	6.0k 1.2×	5.4k 1.5×	2.9k 1.1×	3.8k 1.5×	242	15.7k
Frans C. S. Ramaekers	7.1k 1.2×	2.4k 0.5×	487 0.1×	1.7k 0.7×	1.1k 0.4×	240	13.4k
Norman J. Maitland	5.2k 0.8×	4.6k 0.9×	270 0.1×	780 0.3×	2.2k 0.9×	214	11.4k
Alan L. Ho	4.2k 0.7×	2.8k 0.6×	494 0.1×	1.7k 0.7×	518 0.2×	191	8.2k
Philippe Birembaut	3.6k 0.6×	3.0k 0.6×	290 0.1×	1.7k 0.7×	2.5k 1.0×	200	9.9k
L. Clifton Stephens	3.5k 0.6×	2.4k 0.5×	319 0.1×	1.3k 0.5×	917 0.4×	192	8.8k
Anil K. Rustgi	9.9k 1.6×	9.6k 1.9×	227 0.1×	4.8k 1.9×	4.1k 1.7×	302	20.2k
Jean A. Laissue	1.7k 0.3×	2.7k 0.5×	443 0.1×	843 0.3×	938 0.4×	194	9.4k

Countries citing papers authored by Thomas E. Carey

Since Specialization

Citations

This map shows the geographic impact of Thomas E. Carey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Carey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Carey more than expected).

Fields of papers citing papers by Thomas E. Carey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas E. Carey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Carey. The network helps show where Thomas E. Carey may publish in the future.

Co-authorship network of co-authors of Thomas E. Carey

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas E. Carey. A scholar is included among the top collaborators of Thomas E. Carey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas E. Carey. Thomas E. Carey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Koehl, Bérengère, Cédric Vrignaud, Thankam Nair, et al.. (2023). Lack of the human choline transporter‐like protein SLC44A2 causes hearing impairment and a rare red blood phenotype. EMBO Molecular Medicine. 15(3). e16320–e16320. 6 indexed citations

Brouwer, Andrew F., Heather M. Walline, Yan Kwan Lau, et al.. (2022). Incidence and clearance of oral and cervicogenital HPV infection: longitudinal analysis of the MHOC cohort study. BMJ Open. 12(1). e056502–e056502. 12 indexed citations

Brouwer, Andrew F., Heather M. Walline, Thomas E. Carey, et al.. (2022). Understanding the mechanisms of HPV-related carcinogenesis: Implications for cell cycle dynamics. Journal of Theoretical Biology. 551-552. 111235–111235. 5 indexed citations

Mastrangelo, Michael A., Sara Ture, Charles O. Smith, et al.. (2020). The choline transporter Slc44a2 controls platelet activation and thrombosis by regulating mitochondrial function. Nature Communications. 11(1). 3479–3479. 56 indexed citations

Nisa, Lluís, Paola Francica, Roland Giger, et al.. (2019). Targeting the MET Receptor Tyrosine Kinase as a Strategy for Radiosensitization in Locoregionally Advanced Head and Neck Squamous Cell Carcinoma. Molecular Cancer Therapeutics. 19(2). 614–626. 11 indexed citations

Tan, Yee Sun, Kanokwan Sansanaphongpricha, Yuying Xie, et al.. (2018). Mitigating SOX2-potentiated Immune Escape of Head and Neck Squamous Cell Carcinoma with a STING-inducing Nanosatellite Vaccine. Clinical Cancer Research. 24(17). 4242–4255. 124 indexed citations

Nisa, Lluís, David Barras, Michaela Medová, et al.. (2018). Comprehensive Genomic Profiling of Patient-matched Head and Neck Cancer Cells: A Preclinical Pipeline for Metastatic and Recurrent Disease. Molecular Cancer Research. 16(12). 1912–1926. 23 indexed citations

Eisenberg, Marisa C., Andrew F. Brouwer, Heather M. Walline, et al.. (2018). Dynamics and Determinants of HPV Infection: The Michigan HPV and Oropharyngeal Cancer (M-HOC) Study. BMJ Open. 8(10). e021618–e021618. 9 indexed citations

Koneva, Lada A., Yanxiao Zhang, Shama Virani, et al.. (2017). HPV Integration in HNSCC Correlates with Survival Outcomes, Immune Response Signatures, and Candidate Drivers. Molecular Cancer Research. 16(1). 90–102. 147 indexed citations

10.

Gleber‐Netto, Frederico O., Mei Zhao, Sanchit Trivedi, et al.. (2017). Distinct pattern of TP53 mutations in human immunodeficiency virus–related head and neck squamous cell carcinoma. Cancer. 124(1). 84–94. 18 indexed citations

11.

Zhang, Yanxiao, Lada A. Koneva, Shama Virani, et al.. (2016). Subtypes of HPV-Positive Head and Neck Cancers Are Associated with HPV Characteristics, Copy Number Alterations, PIK3CA Mutation, and Pathway Signatures. Clinical Cancer Research. 22(18). 4735–4745. 110 indexed citations

12.

Walline, Heather M., Christine M. Komarck, Jonathan B. McHugh, et al.. (2016). Genomic Integration of High-Risk HPV Alters Gene Expression in Oropharyngeal Squamous Cell Carcinoma. Molecular Cancer Research. 14(10). 941–952. 41 indexed citations

13.

Vitale‐Cross, Lynn, Daniel Martı́n, Abraham Schneider, et al.. (2015). Prevention of Tumor Growth Driven by PIK3CA and HPV Oncogenes by Targeting mTOR Signaling with Metformin in Oral Squamous Carcinomas Expressing OCT3. Cancer Prevention Research. 8(3). 197–207. 48 indexed citations

14.

Udager, Aaron M., Delphine Rolland, Jonathan B. McHugh, et al.. (2015). High-Frequency Targetable EGFR Mutations in Sinonasal Squamous Cell Carcinomas Arising from Inverted Sinonasal Papilloma. Cancer Research. 75(13). 2600–2606. 97 indexed citations

15.

Zhao, Mei, Daisuke Sano, Curtis R. Pickering, et al.. (2011). Assembly and Initial Characterization of a Panel of 85 Genomically Validated Cell Lines from Diverse Head and Neck Tumor Sites. Clinical Cancer Research. 17(23). 7248–7264. 224 indexed citations

16.

Feng, Felix Y., Hyungjin Myra Kim, Teresa Lyden, et al.. (2010). Intensity-Modulated Chemoradiotherapy Aiming to Reduce Dysphagia in Patients With Oropharyngeal Cancer: Clinical and Functional Results. Journal of Clinical Oncology. 28(16). 2732–2738. 261 indexed citations

17.

Misawa, Kiyoshi, Yo Ueda, Takeharu Kanazawa, et al.. (2008). Epigenetic Inactivation of Galanin Receptor 1 in Head and Neck Cancer. Clinical Cancer Research. 14(23). 7604–7613. 56 indexed citations

18.

Shangary, Sanjeev, Ke Ding, Su Qiu, et al.. (2008). Reactivation of p53 by a specific MDM2 antagonist (MI-43) leads to p21-mediated cell cycle arrest and selective cell death in colon cancer. Molecular Cancer Therapeutics. 7(6). 1533–1542. 75 indexed citations

19.

Verhaegen, Monique, Joshua A. Bauer, Cristina Martín de la Vega, et al.. (2006). A Novel BH3 Mimetic Reveals a Mitogen-Activated Protein Kinase–Dependent Mechanism of Melanoma Cell Death Controlled by p53 and Reactive Oxygen Species. Cancer Research. 66(23). 11348–11359. 117 indexed citations

20.

Wahl, Richard L., Kathryn A. Kimmel, William H. Beierwaltes, & Thomas E. Carey. (1987). Radioimmunodiagnosis of Human-Derived Squamous Cell Carcinoma. Hybridoma. 6(2). 111–119. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact